Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ctDNA Monitoring”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07410611
What this trial is testing

CtDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy

Who this might be right for
Patients With Advanced Oligometastatic Non-small Cell Lung Cancer (NSCLC) Who Have Tested Positive for EGFR Mutations Confirmed by Histopathological Examination
Hebei Medical University Fourth Hospital 84
Not applicableStudy completedNCT04606940
What this trial is testing

Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)

Who this might be right for
Head and Neck CancerAdvanced CancerMetastatic Cancer+2 more
University Health Network, Toronto 18
Not applicableLooking for participantsNCT06792786
What this trial is testing

Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Who this might be right for
Esophageal CancerctDNA
The Central Hospital of Lishui City 30
Not applicableUnknownNCT05976932
What this trial is testing

Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fudan University 20
Not applicableLooking for participantsNCT03791034
What this trial is testing

Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 700
Not applicableUnknownNCT05635630
What this trial is testing

Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention

Who this might be right for
Metastatic Colorectal CancerNo Evidence of Disease StatusctDNA Monitoring
Fudan University 110
Not applicableLooking for participantsNCT07756437
What this trial is testing

Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)Upper Tract Urothelial CarcinomaUrothelial Carcinoma (UC)
AZ Sint-Lucas Gent 70
Not applicableStudy completedNCT03926260
What this trial is testing

Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Centre Hospitalier Departemental Vendee 100
Not applicableUnknownNCT05778955
What this trial is testing

Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma

Who this might be right for
Pediatric Soft Tissue Sarcoma
Sun Yat-sen University 40
Not applicableUnknownNCT04014465
What this trial is testing

Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer

Who this might be right for
Lung CancerEsophageal Cancer
Chinese Academy of Medical Sciences 150
Testing effectiveness (Phase 2)UnknownNCT06315686
What this trial is testing

The Dynamic Monitoring of Cerebrospinal Fluid ctDNA

Who this might be right for
NSCLC
Jiangsu Province Nanjing Brain Hospital 20
Not applicableActive Not RecruitingNCT05029869
What this trial is testing

Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description

Who this might be right for
Gastric CancerctDNA
University Medical Center Ho Chi Minh City (UMC) 100
Not applicableLooking for participantsNCT07080021
What this trial is testing

A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic Adenocarcinoma
Ruijin Hospital 119
Not applicableUnknownNCT05390112
What this trial is testing

Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization

Who this might be right for
Circulating Tumor DNAHepatocellular Carcinoma Non-resectableTransarterial Chemoembolization
University Hospital, Rouen 167
Not applicableUnknownNCT05802420
What this trial is testing

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdvanced CancerMetastatic Cancer
Peking Union Medical College Hospital 100
Not applicableUnknownNCT06479460
What this trial is testing

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

Who this might be right for
Breast CancerNeoadjuvantHER2-positive Breast Cancer+1 more
The First Affiliated Hospital with Nanjing Medical University 50
Not applicableStudy completedNCT07475637
What this trial is testing

Liquid Biopsy Monitoring Of EGFR T790M in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Faculty of Medicine of Tunis 70
Testing effectiveness (Phase 2)Looking for participantsNCT07300449
What this trial is testing

A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents

Who this might be right for
Hepatoblastoma
Sun Yat-sen University 100
Not applicableUnknownNCT06028516
What this trial is testing

MRD Application in Colorectal Cancer Patients

Who this might be right for
Colorectal CancerSurgeryChemotherapy Effect
Shandong First Medical University 200
Not applicableLooking for participantsNCT06420427
What this trial is testing

Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery

Who this might be right for
cfHPV DNA in Plasma of Cervical Cancer Patients
The Third Affiliated Hospital of Guangzhou Medical University 150
Next Page